The risks and benefits of RTPA in acute ischemic stroke for patients at high risk of intracranial haemorrhage and poor functional outcome: a secondary analysis of the IST-3 trial and systematic review of prediction models

Podobne zapisy

• Targeting rtPA in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the IST-3 trial
  od: Whiteley, William N., i wsp.
  Wydane: (2014)
• A novel measure of treatment benefit for an ordinal scale: a case study of the IST-1 and the IST-3 stroke trials
  od: Thompson, Douglas, i wsp.
  Wydane: (2013)
• Predicting risks and benefits of treatment with aspirin in the acute stage of ischaemic stroke: an analysis of 3 large randomised controlled trials
  od: Thompson, Douglas, i wsp.
  Wydane: (2013)
• Response to Letter Regarding Article, “Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: An analysis of the third international stroke trial”
  od: Whiteley, William N., i wsp.
  Wydane: (2014)
• Decreased risk of secondary brain herniation with intracranial pressure monitoring in patients with haemorrhagic stroke
  od: Zeng, Jingsong, i wsp.
  Wydane: (2014)